[1]薛珂,郑捷,曹华.皮肌炎皮肤损害的研究进展[J].中国皮肤性病学杂志,2019,(01):92-95.[doi:10.13735/j.cjdv.1001-7089.201802065]
 XUE Ke,ZHENG Jie,CAO Hua.Progress in Dermatomyositis[J].The Chinese Journal of Dermatovenereology,2019,(01):92-95.[doi:10.13735/j.cjdv.1001-7089.201802065]
点击复制

皮肌炎皮肤损害的研究进展
分享到:

《中国皮肤性病学杂志》[ISSN:1001-7089/CN:61-1197/R]

卷:
期数:
2019年01期
页码:
92-95
栏目:
综述
出版日期:
2019-01-01

文章信息/Info

Title:
Progress in Dermatomyositis
作者:
薛珂郑捷曹华
上海交通大学医学院附属瑞金医院皮肤科,上海200025
Author(s):
XUE KeZHENG JieCAO Hua
(Department of Dermatology,Rui Jin Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200025,China)
关键词:
皮肌炎临床无肌病性皮肌炎皮肤损害
Keywords:
DermatomyositisClinically amyopathic dermatomyositisSkin lesions
分类号:
R 593.26
DOI:
10.13735/j.cjdv.1001-7089.201802065
文献标志码:
A
摘要:
皮肌炎和临床无肌病性皮肌炎的皮肤损害与疾病活动性及预后相关,但目前皮肌炎皮损的发 生机制尚未完全清楚。了解皮肌炎的皮损特点及发生机制,有助于在临床工作中开展针对皮损的治疗 。
Abstract:
Skin lesions of dermatomyositis (DM) and clinical amyopathic dermatomyositis (CADM) are associated with disease activity and prognosis. However,the pathogenesis of skin lesions in dermatomyositis is not fully understood. Recognition of the skin lesions in dermatomyositis is helpful for clinical treatment.

参考文献/References:


[1] Cao H,Parikh TN,Zheng J. Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis[J]. Clin Rheumatol,2009,28(8):979-984.
[2] Cheong WK,Hughes GR,Norris PG,et al. Cutaneous photosensitivity in dermatomyositis[J]. Br J Dermatol,1994,131(2):205-208.
[3] Dourmishev L,Meffert H,Piazena H. Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects[J]. Photodermatol Photoimmunol Photomed,2004,20(5):230-234.
[4] De Paepe B,KK C,JJ M,et al. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages[J]. Ann N Y Acad Sci,2009,1173(1):463-469.
[5] 何黎. 皮肤屏障与相关皮肤病[J]. 中华皮肤科杂志,2012,45(6):455-457.
[6] Rpke MA,Alonso C,Jung S,et al. Effects of glucocorticoids on stratum corneum lipids and function in human skin-A detailed lipidomic analysis[J]. J Dermatol Sci, 2017,88(3):330-338.
[7] Fernandez-Flores A,Cassarino DS. Gottron papules show histopathologic features of localized lymphedema[J]. Am J Dermatopath,2017,39(7):518-523.
[8] Hornung T,Wenzel J. Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis,diagnosis and treatment[J]. Drugs,2014,74(9):981-998.
[9] Wenzel J,Tüting T. An IFN-associated cytotoxic cellular immune response against viral,self-,or tumor antigens is a common pathogenetic feature in "interface dermatitis"[J]. J Invest Dermatol,2008,128(10):392-402.
[10] Zahn S,Barchet W,Rehkmper C,et al. Enhanced skin expression of melanoma differentiation-associated gene 5 (MDA5) in dermatomyositis and related autoimmune diseases[J]. J Am Acad Dermatol,2011,64(5):988-989.
[11] 赵云,吕玲. 多发性肌炎/皮肌炎病因和发病机制研究进展[J]. 复旦学报(医学版), 2009,36(6):779-781.
[12] Merlo G,Clapasson A,Cozzani E,et al. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets[J]. Arch Dermatol Res,2017,309(2):87-95.
[13] Ortizsantamaria V,Babot A,Ferrer C. Anti-MDA5-positive dermatomyositis: an emerging entity with a variable clinical presentation[J]. Scand J Rheumatol,2017,46 (6):509-511.
[14] Cao H,Xia Q,Pan M,et al. Gottron papules and gottron sign with ulceration:a distinctive cutaneous feature in a subset of patients with classic dermatomyositis and clinically amyopathic dermatomyositis[J]. J Rheumatol,2016,43(9):1735-1742. 〖HJ1.95mm〗
[15] Daly ML,Gordon PA,Creamer D. Cutaneous features of dermatomyositis associated with myositis-specific antibodies[J]. Br J Dermatol,2017,176(6):1662-1665.
[16] Sunderktter C,Nast A,Worm M,et al. Guidelines on dermatomyositis-excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology[J]. J Dtsch Dermatol Ges,2016,14(3):321-38.
[17] Griger Z,Nagy-Vincze M,Danko K. Pharmacological management of dermatomyositis[ J]. Expert Rev Clin Pharmacol,2017,10(10):1109-1118.
[18] Hornung T,Ko A,Tuting T,et al. Efficacy of low-dose methotrexate in the treatment of dermatomyositis skin lesions[J]. Clin Exp Dermatol,2012,37(2):139-142.
[19] Aggarwal R,Loganathan P,Koontz D,et al. Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab[J]. Rheumatology (Oxford),2016,56(2):247-254.
[20] Kim JE,Jeong MG,Lee HE,et al. Successful treatment of cutaneous lesions of dermatomyositis with topical pimecrolimus[J]. Ann Dermatol,2011,23(3):348-351.
[21] Ge Y,Zhou H,Shi J,et al. The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review[J]. Clin Rheumatol, 2015,34(12):2097-2103.
[22] Kaveri SV,Lecerf M,Saha C,et al. Intravenous immunoglobulin and immune response[J]. Clin Exp Immunol,2014,178( Suppl 1):94-96.
[23] Galimberti F,Li Y,Fernandez AP. Intravenous immunoglobulin for treatment of dermatomyositis-associated dystrophic calcinosis[J]. J Am Acad Dermatol,2015,73 (1):174-176.
[24] Rowe B,Yosipovitch G. Paraneoplastic itch management[J]. Curr Probl Dermatol, 2016,50:149-54.

相似文献/References:

[1]罗寰,杨金良,阮海玲,等.皮肌炎合并纵隔及皮下气肿1例[J].中国皮肤性病学杂志,2015,(03):299.[doi:10.13735/j.cjdv.1001-7089.201405192]
 LUO Huan,YANG Jing liang,RUAN Hai ling,et al.A Case of Dermatomyositis with Mediastinal and Subcutaneous Emphysema[J].The Chinese Journal of Dermatovenereology,2015,(01):299.[doi:10.13735/j.cjdv.1001-7089.201405192]
[2]蔡云雅,方红.皮肌炎/多发性肌炎86例的甲状腺功能分析[J].中国皮肤性病学杂志,2015,(04):365.[doi:10.13735/j.cjdv.1001-7089.201406204]
 CAI Yun ya,FANG Hong.Clinical Analysis of Thyroid Function on 86 Cases of Dermatomyositis/Polymyositis Patients[J].The Chinese Journal of Dermatovenereology,2015,(01):365.[doi:10.13735/j.cjdv.1001-7089.201406204]
[3]白艳玲,宋智琦.皮肌炎并发皮肤弥漫大B细胞淋巴瘤1例[J].中国皮肤性病学杂志,2015,(07):712.[doi:10.13735/j.cjdv.1001-7089.201407077]
 BAI Yan ling,SONG Zhi qi.A Case of Dermatomyositis Complicated with Skin Diffuse Large B Cell Lymphoma[J].The Chinese Journal of Dermatovenereology,2015,(01):712.[doi:10.13735/j.cjdv.1001-7089.201407077]
[4]马毳毳,刘艳,尹佳锋,等.皮肤科住院患者血清铁蛋白及鳞状上皮细胞癌抗原的检测[J].中国皮肤性病学杂志,2015,(10):1023.[doi:10.13735/j.cjdv.1001.7089.201412150]
 MA Cui cui,LIU Yan,YIN Jia feng,et al.Detection of Serum Ferritin and Squamous Cell Carcinoma Antigen in Hospitalized Patients[J].The Chinese Journal of Dermatovenereology,2015,(01):1023.[doi:10.13735/j.cjdv.1001.7089.201412150]
[5]潘伦,熊霞,钟建桥.成人皮肌炎42例生活质量调查[J].中国皮肤性病学杂志,2016,(06):621.[doi:10.13735/j.cjdv.1001-7089.201508021]
 PAN Lun,XIONG Xia,ZHONG Jian-qiao.Study on the Quality of Life of 42 Adult Dermatomyositis Patients[J].The Chinese Journal of Dermatovenereology,2016,(01):621.[doi:10.13735/j.cjdv.1001-7089.201508021]
[6]谭艳平,刘志刚.皮肌炎/多发性肌炎病因及发病机制的研究进展[J].中国皮肤性病学杂志,2016,(06):634.[doi:10.13735/j.cjdv.1001-7089.201504108]
 TAN Yan-ping,LIU Zhi-gang.Advancement in the Study of Pathogenesis of Dermatomyositis/Polymyositis[J].The Chinese Journal of Dermatovenereology,2016,(01):634.[doi:10.13735/j.cjdv.1001-7089.201504108]
[7]李晓云,钮含春,田恒创,等.皮肌炎中医证型与调节性T淋巴细胞的相关性[J].中国皮肤性病学杂志,2017,(02):209.[doi:10.13735/j.cjdv.1001-7089.201606097]
 LI Xiao-yun,NIU Han-chun,TIAN Heng-chuang,et al.Relationship between TCM Syndrome and Regulatory T Cells in Peripheral Blood from Patients with Dermatomyositis[J].The Chinese Journal of Dermatovenereology,2017,(01):209.[doi:10.13735/j.cjdv.1001-7089.201606097]
[8]郑玉洁,谢宜彤,林景荣.肺部错构瘤合并皮肌炎1例[J].中国皮肤性病学杂志,2017,(07):784.[doi:10.13735/j.cjdv.1001-7089.201606009]
 ZHENG Yu-jie,XIE Yi-tong,LIN Jing-rong.A Cases of Pulmonary Hamartoma Complicated with Dermatomyositis[J].The Chinese Journal of Dermatovenereology,2017,(01):784.[doi:10.13735/j.cjdv.1001-7089.201606009]
[9]余先华,李季,佘小光,等.皮肌炎合并Vogt-小柳综合征1例[J].中国皮肤性病学杂志,2014,(03):294.
 YU Xian-hua,LI Ji,SHE Xiao-guang,et al.A Case of Dermatomyositis with Vogt-Koyanagi Syndrome[J].The Chinese Journal of Dermatovenereology,2014,(01):294.
[10]肖遥,周兴丽,兰英,等.毛囊角化病样表现的皮肌炎1例及文献复习[J].中国皮肤性病学杂志,2019,(05):569.[doi:10.13735/j.cjdv.1001-7089.201808124]
 XIAO Yao,ZHOU Xingli,LAN Ying,et al.A Case of Dermatomyositis Presenting with Keratosis Follicularis-Like Lesions and Literature Review[J].The Chinese Journal of Dermatovenereology,2019,(01):569.[doi:10.13735/j.cjdv.1001-7089.201808124]
[11]李丹,曾碧冰,张峰,等.临床无肌病性皮肌炎12例临床分析及抗MDA5抗体对其预后的影响[J].中国皮肤性病学杂志,2015,(09):917.[doi:10.13735/j.cjdv.1001-7089.201502002]
 LI Dan,ZENG Bi bing,ZHANG Feng,et al.Clinical Analysis of 12 Clinical Amyopathic Dermatomyositis and the Influence of Anti MDA5 to Prognosis[J].The Chinese Journal of Dermatovenereology,2015,(01):917.[doi:10.13735/j.cjdv.1001-7089.201502002]

备注/Memo

备注/Memo:
[基金项目]国家自然科学基金面上项目(81573037);国家临床重点专科建设项目 (2012649);上海市科委医学引导类项目(134119a6100);上海申康医院发展中心临床创新三年行 动计划(16CR3084B);上海交通大学医学院高峰学科——临床医学研究型医师(20172009)
[作者单位]上海交通大学医学院附属瑞金医院皮肤科,上海200025
[通讯作者]曹华,E-mail:drcaohua@126.com
更新日期/Last Update: 2018-12-20